Skip to content

Pulsed radiofrequency for the treatment of low back pain.

Pulsed radiofrequency for the treatment of low back pain with radicular pain and its correlation with Quantitative Sensory Testing–a prospective, parallel group, randomized, double blind, sham controlled trial.

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/01/011066
Enrollment
100
Registered
2018-01-01
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Low back pain with radicular pain. Health Condition 2: G541- Lumbosacral plexus disorders

Interventions

Intervention1: Group PRF: Patient in this group will receive Pulsed Radio Frequency (PRF) of Dorsal Route Ganglion (DRG) Control Intervention1: group Sham: Patient in this group will have only Pulsed

Sponsors

Post Graduate Institute of Medical Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Male and female patients over the age of 18 years who have a unilateral lumbar radicular pain due to disc herniation on magnetic resonance imaging, correlating clinically in terms of level and side and are due for elective PRF to treat their pain.

Exclusion criteria

Exclusion criteria: 1. Other pain conditions that may confound the assessment of their radicular pain, as judged by the investigator(s) 2. Patients who have had previous back surgery to treat their radicular pain (‘failed back surgery syndrome’) 3. Patients with a known condition that may preclude their participation in the study, as judged by the investigator(s) 4. Patients taking anticoagulant or antiplatelet medication (except for low-dose aspirin), or known to have coagulation disorders, as judged by the investigator(s) 5. Patients with localized or systemic sepsis a. Localized sepsis: infection of the skin at site of entry of the PRF probe 6. Breast-feeding women 7. Positive pregnancy test 8. Participation in other clinical trials, use of investigational drugs or procedures or use of experimental medications within 30 days prior to the enrolment visit 9. Previous randomisation in the present study 10. Females must not be breastfeeding.

Design outcomes

Primary

MeasureTime frame
Proportion of patients achieving effective pain relief (EPR) in each group will be considered as primary endpoint. We will define the approach as “effective ? when pain relief will be = 50% reduction from baseline on Verbal Numerical Rating Scale.Timepoint: 3 months after the procedure

Secondary

MeasureTime frame
To assess the Quantitative sensory testing (QST) measurements, changes in functional disability, changes in quality of life measured by health-related quality of life tools, and improved clinical and cost effectiveness using quality-adjusted life years measurement.Timepoint: 1. At baseline. 2. On week after procedure 3. at 3 months post-procedure.

Countries

India

Contacts

Public ContactBabita Ghai

Post Graduate Institute of Medical Education and Research

ghaibabita1@gmail.com7087009533

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026